Many RhD-negative pregnant women lose detectable anti-D protection before delivery, which may leave a small window of risk for HDFN.
Learn more about what a critical titer is in HDFN and how it can change depending on which antibody type caused the disease.
Learn more about how you and your doctors can monitor and track your baby’s movement patterns during pregnancy.
Researchers found phototherapy, a common treatment for HDFN, is associated with a slightly higher cancer risk.
Courtesy Getty Images Learn more about the resources needed to treat HDFN and what to look for when choosing a hospital for your delivery and care. If your infant has been diagnosed with or is at risk ...
Conflicting guidance on RhD immune globulin is giving way to clearer recommendations that may spare many patients unnecessary ...
Researchers used AI-enhanced methods to identify rare noncoding RhD variants that could affect the severity of HDFN.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results